Customer Outcomes & Value Experiencing A New Monitoring Technology

Not Applicable

• Conditions: Diabetes Mellitus
• Interventions: Device: LifeScan's new BGMS

• Registration Number: NCT04262700
• Lead Sponsor: LifeScan Scotland Ltd

Brief Summary

To investigate whether novel insight features in new Blood Glucose Monitoring System (BGMs) can improve glycemic control.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-07
• Study First Submitted: 2020-02-07
• Study First Submitted QC: 2020-02-07
• Study First Posted: 2020-02-10
• Status Verified: 2020-09
• Last Update Submitted: 2020-09-08
• Last Update Posted: 2020-09-09
• Primary Completion: 2020-10-01
• Study Completion: 2020-10-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Intervention 01	LifeScan's new BGMS	Subjects use new LifeScan provided BGMS for 12 weeks.

Primary Outcome Measures

Name	Time	Method
A1c change from baseline after 12 weeks	12 weeks	A1c change from baseline after 12 weeks in subjects using new BGMS compared to subjects' pre-study glycemic control

Trial Locations

Locations (2)

Highland Diabetes Institute; 🇬🇧 Inverness, United Kingdom

Royal Infirmary of Edinburgh; 🇬🇧 Edinburgh, Lothian, United Kingdom